Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in Children (SCOUT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02637687
Recruitment Status : Recruiting
First Posted : December 22, 2015
Last Update Posted : January 24, 2022
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 22, 2026
Estimated Study Completion Date : September 22, 2026
Publications automatically indexed to this study by Identifier (NCT Number):